169 related articles for article (PubMed ID: 36680624)
21. Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients.
Wroński M; Arbit E
J Neurosurg; 2000 Jul; 93(1):9-18. PubMed ID: 10883899
[TBL] [Abstract][Full Text] [Related]
22. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
[TBL] [Abstract][Full Text] [Related]
23. Survival after surgical resection of isolated pulmonary metastases from malignant melanoma.
Andrews S; Robinson L; Cantor A; DeConti RC
Cancer Control; 2006 Jul; 13(3):218-23. PubMed ID: 16885918
[TBL] [Abstract][Full Text] [Related]
24. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome.
Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI
Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714
[TBL] [Abstract][Full Text] [Related]
25. Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma.
Caralt M; Martí J; Cortés J; Fondevila C; Bilbao I; Fuster J; García-Valdecasas JC; Sapisochín G; Balsells J; Charco R
J Hepatobiliary Pancreat Sci; 2011 Mar; 18(2):268-75. PubMed ID: 21057964
[TBL] [Abstract][Full Text] [Related]
26. Metastatic melanoma: a regional review and future directions.
Khan KH; Goody RB; Hameed H; Jalil A; Coyle VM; McAleer JJ
Tumori; 2012; 98(5):575-80. PubMed ID: 23235751
[TBL] [Abstract][Full Text] [Related]
27. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
28. Skin metastases of malignant melanoma: a clinical and prognostic survey.
Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
[TBL] [Abstract][Full Text] [Related]
29. Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma.
White ML; Atwell TD; Kurup AN; Schmit GD; Carter RE; Geske JR; Kottschade LA; Pulido JS; Block MS; Jakub JW; Callstrom MR; Markovic SN
Mayo Clin Proc; 2016 Mar; 91(3):288-96. PubMed ID: 26827235
[TBL] [Abstract][Full Text] [Related]
30. Resection of pulmonary metastases from malignant melanoma: results of a 16-year experience.
Pogrebniak HW; Stovroff M; Roth JA; Pass HI
Ann Thorac Surg; 1988 Jul; 46(1):20-3. PubMed ID: 3382281
[TBL] [Abstract][Full Text] [Related]
31. Surgical treatment of melanoma metastases to the small bowel: A single cancer referral center real-life experience.
Gallino G; Maurichi A; Patuzzo R; Mattavelli I; Barbieri C; Leva A; Valeri B; Cossa M; Galeone C; Pelucchi C; Santinami M
Eur J Surg Oncol; 2021 Feb; 47(2):409-415. PubMed ID: 32917431
[TBL] [Abstract][Full Text] [Related]
32. Primary melanoma of the hand: An algorithmic approach to surgical management.
Sinno S; Wilson S; Billig J; Shapiro R; Choi M
J Plast Surg Hand Surg; 2015; 49(6):339-45. PubMed ID: 26051472
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic liver resection for metastatic melanoma.
Aghayan DL; Kazaryan AM; Fretland ÅA; Sahakyan MA; Røsok BI; Bjørnbeth BA; Edwin B
Surg Endosc; 2018 Mar; 32(3):1470-1477. PubMed ID: 28916919
[TBL] [Abstract][Full Text] [Related]
35. Management of in-transit metastases from cutaneous malignant melanoma.
Hayes AJ; Clark MA; Harries M; Thomas JM
Br J Surg; 2004 Jun; 91(6):673-82. PubMed ID: 15164434
[TBL] [Abstract][Full Text] [Related]
36. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
37. The natural history of resectable metastatic melanoma (Stage IVA melanoma).
Feun LG; Gutterman J; Burgess MA; Hersh EM; Mavligit G; McBride CM; Benjamin RS; Richman SP; Murphy WK; Bodey GP; Brown BW; Mountain CF; Leavens ME; Freireich EJ
Cancer; 1982 Oct; 50(8):1656-63. PubMed ID: 7116298
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
39. Stability, prognostic factors and survival of spinal bone metastases in malignant melanoma patients after palliative radiotherapy.
Bostel T; Förster R; Schlampp I; Wolf R; Serras AF; Mayer A; Bruckner T; Welzel T; Schmidberger H; Debus J; Rief H
Tumori; 2016; 102(2):156-61. PubMed ID: 26166220
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
